1. Home
  2. GKOS vs FMS Comparison

GKOS vs FMS Comparison

Compare GKOS & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$180.54

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

HOLD

Current Price

$22.58

Market Cap

11.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
FMS
Founded
1998
1996
Country
United States
Germany
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Misc Health and Biotechnology Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
11.5B
IPO Year
2015
2005

Fundamental Metrics

Financial Performance
Metric
GKOS
FMS
Price
$180.54
$22.58
Analyst Decision
Strong Buy
Hold
Analyst Count
13
7
Target Price
★ $199.31
$23.72
AVG Volume (30 Days)
979.8K
★ 1.2M
Earning Date
10-28-2026
11-03-2026
Dividend Yield
N/A
★ 2.68%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $507,442,000.00
N/A
Revenue This Year
$36.30
N/A
Revenue Next Year
$23.25
$3.49
P/E Ratio
★ N/A
$15.62
Revenue Growth
★ 32.33
N/A
52 Week Low
$80.91
$20.02
52 Week High
$191.62
$26.95

Technical Indicators

Market Signals
Indicator
GKOS
FMS
Relative Strength Index (RSI) 65.62 54.76
Support Level $175.04 $22.37
Resistance Level $184.68 $22.59
Average True Range (ATR) 6.45 0.41
MACD 1.90 0.16
Stochastic Oscillator 80.18 78.60

Price Performance

Historical Comparison
GKOS
FMS

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Share on Social Networks: